Passion and commitment coming together to innovate and accelerate pancreatic cancer research.

Passion and commitment coming together to innovate and accelerate pancreatic cancer research.


How can I find a pancreatic cancer clinical trial?

The Pancreatic Cancer Collective is pleased to connect interested parties with EmergingMed, a free and confidential clinical trial matching service that will help guide you through a search and referral process to find a clinical trial that may be right for you or your loved one. You can speak with an expert who can help to identify a pancreatic cancer clinical trial by calling toll-free 877.769.4829, Monday through Friday, 9:00am – 6:00pm ET. You can also get help online, using the form found at Services are also available in Spanish, if needed.

How will teams be selected?

The Pancreatic Cancer Collective will issue solicitations for competitive proposals. These funding opportunities will be posted on the Collective web site at where you can also sign up to receive future notifications. The first funding opportunity will be posted on proposal central and notifications will be sent via email to broad cancer researcher distribution lists. Funding opportunities may involve “Requests for Applications,” “Calls for Ideas,” or other similar vehicles.

Teams will be selected by a Joint Scientific Committee (JSAC) comprising leading pancreatic and cancer researchers, under the leadership of Phillip A. Sharp, PhD, chair of the Stand Up To Cancer Scientific Advisory Committee and David Tuveson, MD, PhD, chief scientist of Lustgarten Foundation for Pancreatic Cancer Research.  After full proposals / applications are rigorously reviewed and scored by the JSAC, finalists may be invited to appear before the JSAC to make a formal presentation and engage in a Q&A period with the JSAC.  Recommendations of the JSAC are subject to ratification by the Stand Up To Cancer Council of Founders and Advisors, the Boards of Directors of the Entertainment Industry Foundation and Lustgarten Foundation for Pancreatic Cancer Research. Awards will not be announced until detailed scopes of work and budgets are determined to be adequately developed.

How will the work of teams be reviewed?

Teams funded by the Pancreatic Cancer Collective will be subject to rigorous reviews, including written reports and in-person meetings, consistent with the Stand Up To Cancer model of scientific oversight. These reviews will be conducted under the leadership of Dr. Sharp and Dr. Tuveson, involving scientific advisors participating in the JSAC selection of the team and other leading pancreatic and cancer researchers. Release of funds for subsequent research tasks may be dependent on the progress and milestones reported in these reviews. Scopes of work may be adjusted based on research outcomes since the prior review.  Progress reports are received and ratified by the SU2C CFA. Lay summaries of the progress reports will be posted on the Collective web site providing accountable and transparent reporting on the outcomes made possible by funds raised for this research.

Where can I submit my idea for pancreatic cancer research to be considered for funding?

The Pancreatic Cancer Collective does not accept unsolicited proposals for research. If you are interested in being notified of funding opportunities, you can sign up on this web site at